WELCEFO 200 contains Cefpodoxime 200 mg, a third-generation oral cephalosporin positioned for selected susceptible bacterial infections. A strong PCD Pharma Antibiotic portfolio product.
Susceptible bacterial infections.
Yes.
Complete the prescribed course and avoid unnecessary antibiotic use. Inform the physician about cephalosporin/penicillin allergy and significant renal impairment.
Diarrhea, nausea, vomiting, abdominal discomfort, headache and rash may occur.
WELCEFO 200: Cefpodoxime inhibits bacterial cell-wall synthesis, resulting in inhibition and destruction of susceptible bacteria.
